- Latest Stories
- Commentary and Analysis
8:39AM ET 4/13/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
7:03AM ET 3/21/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
11:24AM ET 1/05/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
8:29AM ET 1/05/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
7:46AM ET 1/04/2022 MT NewswiresApplied Therapeutics (APLT) has an average investment rating of outperform and price targets ranging from $7 to $85, according to analysts polled by...
4:04PM ET 1/03/2022 MT NewswiresHealth care stocks trimmed a portion of its Monday retreat this afternoon, with the NYSE Health Care Index falling 1.1% while the SPDR Health Care Select...
2:22PM ET 1/03/2022 MT NewswiresApplied Therapeutics (APLT) said it will put a hold on submission of a new drug application for its prospective galactosemia treatment AT-007 following...
1:48PM ET 1/03/2022 MT NewswiresHealth care stocks were retreating this afternoon, with the NYSE Health Care Index falling 1.5% while the SPDR Health Care Select Sector ETF (XLV) was down...
1:30PM ET 1/03/2022 MT NewswiresHealth care stocks were retreating this afternoon, with the NYSE Health Care Index falling 1.5% while the SPDR Health Care Select Sector ETF (XLV) was down...
10:12AM ET 1/03/2022 MT Newswires(Updating with stock movement information) Applied Therapeutics (APLT) said Monday it will put a hold on submission of a new drug application for its...